|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | ||
| Net income | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Dividend and interest income on Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expense | ||
| Accrued expense | ||
| Net Cash Used in Operating Activities | ||
| Cash flows from investing activities: | ||
| Investment held in Trust Account | ||
| Extension fee deposited into Trust Account | ||
| Net Cash Used in Financing Activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of public units, including over-allotment, net of underwriters' discount | ||
| Proceeds from sale of private placement units, including over-allotment | ||
| Proceed from promissory notes, related parties | ||
| Advances from related party | ||
| Payment of offering costs | ||
| Net Cash Provided by Financing Activities | ||
| Net Change in Cash | ||
| Cash at beginning of the year | ||
| Cash, end of the year | ||
| Supplemental Disclosure of Cash Flow Information: | ||
| Accrued expense paid by Sponsor | ||
| Deferred offering costs paid by Sponsor for settlement of subscription receivable | ||
| Deferred offering costs paid by Sponsor | ||
| Issuance of representative shares | ||
| Reclassification of ordinary shares subject to redemption | ||
| Initial accretion of carrying value for public shares to redemption value | ||
| Subsequent accretion of carrying value for public shares to redemption value | ||
| Allocation of offering costs to ordinary shares subject to redemption |
Loading...
